Skip to content
10-Q

Quarterly Report

SYMMETRY MEDICAL INC.

0001292055-14-000010

← back to feed
Filed
Nov 6, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Nov 3, 2014 37.55M sh
Shares Diluted Q3 2014 · Sep 27, 2014 37.09M sh
Shares Diluted Q3 2014 · Sep 27, 2014 37.05M sh
Shares Diluted Q3 2014 · Sep 28, 2013 36.35M sh
Shares Diluted Q3 2014 · Sep 28, 2013 36.31M sh
Capex Q3 2014 · Sep 27, 2014 $11.4M
Capex Q3 2014 · Sep 28, 2013 $7.79M
Operating Cash Flow Q3 2014 · Sep 27, 2014 $33.83M
Operating Cash Flow Q3 2014 · Sep 28, 2013 $34.39M
Long Term Debt Q3 2014 · Sep 27, 2014 $170M
Long Term Debt Q3 2014 · Dec 28, 2013 $165.45M
Cash And Equivalents Q3 2014 · Sep 27, 2014 $27.18M
Cash And Equivalents Q3 2014 · Dec 28, 2013 $7.36M
Cash And Equivalents Q3 2014 · Sep 28, 2013 $4.9M
Cash And Equivalents Q3 2014 · Dec 29, 2012 $9.82M
Stockholders Equity Q3 2014 · Sep 27, 2014 $279.28M
Stockholders Equity Q3 2014 · Dec 28, 2013 $284.8M
Current Liabilities Q3 2014 · Sep 27, 2014 $52.8M
Current Liabilities Q3 2014 · Dec 28, 2013 $52.96M
Total Liabilities Q3 2014 · Sep 27, 2014 $232.05M
Total Liabilities Q3 2014 · Dec 28, 2013 $231.04M
Current Assets Q3 2014 · Sep 27, 2014 $151.21M
Current Assets Q3 2014 · Dec 28, 2013 $134.18M
Total Assets Q3 2014 · Sep 27, 2014 $511.32M
Total Assets Q3 2014 · Dec 28, 2013 $515.84M
Eps Diluted Q3 2014 · Sep 27, 2014 $0.04
Eps Diluted Q3 2014 · Sep 27, 2014 −$0.11
Eps Diluted Q3 2014 · Sep 28, 2013 −$0.95
Eps Diluted Q3 2014 · Sep 28, 2013 −$0.93
Eps Basic Q3 2014 · Sep 27, 2014 $0.04
Eps Basic Q3 2014 · Sep 27, 2014 −$0.11
Eps Basic Q3 2014 · Sep 28, 2013 −$0.95
Eps Basic Q3 2014 · Sep 28, 2013 −$0.93
Rd Expense Q3 2014 · Sep 27, 2014 $1.26M
Rd Expense Q3 2014 · Sep 27, 2014 $3.66M
Rd Expense Q3 2014 · Sep 28, 2013 $1.12M
Rd Expense Q3 2014 · Sep 28, 2013 $3.46M
Net Income Q3 2014 · Sep 27, 2014 $1.32M
Net Income Q3 2014 · Sep 27, 2014 −$3.98M
Net Income Q3 2014 · Sep 28, 2013 −$34.52M
Net Income Q3 2014 · Sep 28, 2013 −$33.64M
Operating Income Q3 2014 · Sep 27, 2014 $3.06M
Operating Income Q3 2014 · Sep 27, 2014 $5.46M
Operating Income restated Q3 2014 · Sep 28, 2013 −$40.29M
Operating Income restated Q3 2014 · Sep 28, 2013 −$29.19M
Gross Profit Q3 2014 · Sep 27, 2014 $25.71M
Gross Profit Q3 2014 · Sep 27, 2014 $77.61M
Gross Profit restated Q3 2014 · Sep 28, 2013 $25.24M
Gross Profit restated Q3 2014 · Sep 28, 2013 $76.77M
Cost Of Revenue Q3 2014 · Sep 27, 2014 $70.22M
Cost Of Revenue Q3 2014 · Sep 27, 2014 $216.48M
Cost Of Revenue restated Q3 2014 · Sep 28, 2013 $70.43M
Cost Of Revenue restated Q3 2014 · Sep 28, 2013 $213.72M
Revenue Q3 2014 · Sep 27, 2014 $95.94M
Revenue Q3 2014 · Sep 27, 2014 $294.09M
Revenue restated Q3 2014 · Sep 28, 2013 $95.67M
Revenue restated Q3 2014 · Sep 28, 2013 $290.49M